Fabino Life Sciences IPO vs Vivo Collaboration Solutions IPO
Comparison between Fabino Life Sciences IPO and Vivo Collaboration Solutions IPO.
IPO Details
Fabino Life Sciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vivo Collaboration Solutions IPO is a SME Fixed Price proposed to list at NSE SME.
The total issue size of Fabino Life Sciences IPO is up to ₹3.07 Cr whereas the issue size of the Vivo Collaboration Solutions IPO is up to ₹4.17 Cr. The final issue price of Fabino Life Sciences IPO is ₹36.00 per share and of Vivo Collaboration Solutions IPO is ₹82.00 per share.
Fabino Life Sciences IPO opens on Dec 31, 2021, while Vivo Collaboration Solutions IPO opens on Dec 20, 2021. The closing date of Fabino Life Sciences IPO and Vivo Collaboration Solutions IPO is Jan 05, 2022, and Dec 23, 2021, respectively.
In the Fabino Life Sciences IPO Retail Individual Investors (RII) are offered 4,26,000 shares while in Vivo Collaboration Solutions IPO retail investors are offered 4,26,000 shares. Qualified Institutional Buyers (QIB) are offered in Fabino Life Sciences IPO and in Vivo Collaboration Solutions IPO.